Named one of Baltimore's Top Doctors for 2009 by Baltimore Magazine, Dr. Kershner is Director of Women's Cardiac Services at MedStar Union Memorial Hospital. Her research has been published in Chest and Current Treatment Options in Cardiovascular Medicine. She is a fellow of the American College of Cardiology, board certified in Cardiovascular Disease, and a member of the Massachusetts Medical Society.
Dr. Kershner received her Doctor of Osteopathic Medicine degree from the Philadelphia College of Osteopathic Medicine and her Master of Public Health from the Harvard School of Public Health in Boston. She completed both an internship and residency in Internal Medicine at MedStar Franklin Square Medical Center and a fellowship in Cardiology at Brigham and Women's Hospital/Harvard Medical School.
Dr. Kershner's research interests include
- Women's cardiovascular health
- Preventive medicine
- Clinical cardiology
- Cardiac drug trials
- Cardiovascular disease
A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Dr. Kershner is a principal investigator on this study, sponsored by Hoffman-La Roche, Inc. This double-blind, randomized placebo-controlled study is being conducted to evaluate the ability of RO4607381 to reduce cardiovascular morbidity and mortality in stable coronary heart disease patients with recent acute coronary syndrome and to evaluate long-term safety of the drug.
Stabilization of Plaques Using Darapladib-Thrombolysis in the Myocardial Infarction 52 [SOLID-TIMI 52] Trial
Dr. Kershner is a principal investigator on this trial to test whether darapladib can safely lower the chances of having a cardiovascular event (e.g., heart attack or stroke) in patients with acute coronary syndrome.
- Research Areas